School of Pharmacy alum and Teva R&D executive Mehran Yazdanian shares what it takes to bring a biosimilar to market and what changes in the field mean for patients and pharmacists.
Pharmaceutical Development
Leadership, Learning, and Drug Development
Alum Elham Nejati (PhD ’12) advances new therapeutics through formulation and process development at Gilead Sciences.
New Lachman Institute at the School of Pharmacy Advances Pharmaceutical Development
Through the support of renowned alum Leon Lachman, the Institute harnesses expertise and enhances collaboration to move therapies from the lab into the clinic.